Status:
COMPLETED
Effect of Ischemic Preconditioning on Atrial Fibrillation After Electrocardioversion
Lead Sponsor:
St. Josefs-Hospital Wiesbaden GmbH
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Remote ischemic preconditioning is one way to influence the success of therapy in cardiovascular patients. By means of remote ischemic preconditioning the incidence of atrial fibrillation after cardia...
Eligibility Criteria
Inclusion
- Patients with paroxysmal or persistent atrial fibrillation who give written informed consent to participate in the study
- Age \> 18 years
- Consent capacity
Exclusion
- Age under 18 years
- Pregnancy
- Lack of consent capacity
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05342220
Start Date
April 1 2022
End Date
June 30 2024
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Josefs-Hospital Wiesbaden
Wiesbaden, Hesse, Germany, 65189